Transmission Dynamics of Carbapenemase Genes in CREC During COVID-19

Study Background and Research Question

The global escalation of carbapenem-resistant Enterobacteriaceae (CRE) poses a significant threat to public health, with Enterobacter cloacae complex (CREC) emerging as a prominent multidrug-resistant Gram-negative pathogen. The COVID-19 pandemic has intensified these challenges by increasing antibiotic usage and disrupting standard infection control, thereby accelerating the emergence and spread of resistant organisms. Despite these concerns, detailed molecular and epidemiological insights into carbapenemase-encoding genes (CEGs) in CREC during the pandemic period have been limited. The reference study by Chen et al. addresses this gap, systematically investigating the characterization and transmission dynamics of CEGs in CREC isolates from eight teaching hospitals in Guangdong, China, spanning December 2022 to June 2024.

Key Innovation from the Reference Study

The study's primary innovation lies in its comprehensive, real-world surveillance of CREC in a pandemic context, combining molecular genotyping, plasmid analysis, and conjugation experiments. By analyzing 54 CREC isolates, the authors provide an unprecedented snapshot of how CEGs are distributed across chromosomes and plasmids, and quantify the horizontal transfer efficiency of key resistance determinants such as bla_NDM-1, bla_IMP, and bla_KPC-2. Notably, the work elucidates the predominance of bla_NDM-1—especially when plasmid-borne—as a driver of high-level, multidrug-resistant phenotypes. The mapping of mobile genetic elements (MGEs), particularly ISEcp1, further advances our understanding of the vehicles facilitating rapid gene dissemination during healthcare disruptions.

Methods and Experimental Design Insights

The research leveraged a multi-pronged approach:

• Isolate Collection: 54 non-redundant CREC strains were obtained from diverse clinical departments across eight tertiary hospitals.
• Genetic Screening: Sodium Dodecyl Sulfate (SDS) plasmid elimination and PCR identified the presence and location (chromosomal vs. plasmid) of CEGs.
• Broth Microdilution: This method quantified antibiotic susceptibility, with resistance profiles compared between CEG-positive and CEG-negative groups.
• Conjugation Experiments: Plasmid transferability was assessed using filter mating and PCR confirmation, measuring horizontal gene transfer efficiency.
• Genotyping: ERIC-PCR, analyzed via NTSYS software, delineated genetic relationships and potential clonal outbreaks.
• Mobile Genetic Element Analysis: Six classes of MGEs were screened, with ISEcp1 being the most prevalent.

This rigorous design enabled both epidemiological and mechanistic insights into resistance gene propagation during a period of heightened clinical vulnerability.

Core Findings and Why They Matter

The study revealed several pivotal results:

• High Prevalence of CEGs: 85.19% of isolates harbored carbapenemase genes, with bla_NDM-1 present in 33.33% on both chromosomes and plasmids, and 46.30% exclusively on plasmids. Smaller proportions carried bla_IMP or both bla_NDM-1 and bla_KPC-2.
• Multidrug Resistance: CEG-positive strains exhibited markedly higher resistance to multiple agents, including imipenem, cefepime, gentamicin, ceftazidime/avibactam, ciprofloxacin, and levofloxacin, compared to CEG-negative strains (statistically significant).
• Horizontal Transfer Efficiency: Plasmid conjugation experiments showed that 95.65% of CEG-positive isolates could transfer resistance genes, with the bla_NDM-1 and bla_IMP genes being especially mobile.
• Mobile Genetic Elements: ISEcp1 was found in 87.04% of isolates; co-occurrence of multiple MGEs was common, suggesting complex recombination and transfer networks.
• Genotypic Diversity and Epidemiology: Seventeen distinct genotypes were identified, with types E and G most prevalent. CRECs were disproportionately isolated from male, elderly, and respiratory medicine patients, and from sputum samples.

These findings underscore the formidable adaptability of CREC during pandemic stress, as well as the clinical challenge posed by mobile, multidrug-resistant plasmids. The study also highlights the need for ongoing surveillance and molecular epidemiology in hospital environments to inform infection control strategies.

Comparison with Existing Internal Articles

Recent internal reviews, such as "Transmission Dynamics of Carbapenemase Genes in CREC: Insights from Guangdong", corroborate the reference study's depiction of high resistance gene prevalence and the epidemiological complexity of CREC in regional hospitals. These reviews emphasize the convergence between genomic surveillance and practical experimental workflows, a theme further developed in "Ertapenem Sodium Salt: Precision Tools for Resistance Research", which details the application of antibiotics like Ertapenem sodium salt for modeling resistance in vitro. Both sources reinforce the value of integrating molecular findings with laboratory assay design to probe resistance mechanisms and gene transfer events.

Notably, the internal article "Ertapenem (sodium salt): Advanced Workflows for Resistance" discusses the role of broad-spectrum carbapenems in susceptibility testing and resistance gene transfer studies, directly aligning with the need for robust tools to dissect the multidrug phenotypes reported by Chen et al.

Limitations and Transferability

While the study offers a granular view of CEG epidemiology in one Chinese province, several limitations should be noted. The sample size (54 isolates) and regional focus may constrain generalizability to other geographic or clinical settings. Additionally, the reliance on PCR and SDS elimination is robust for gene detection but may miss novel or uncommon resistance determinants. The dynamic hospital environment during COVID-19, characterized by increased antibiotic use and resource strain, may also not fully reflect post-pandemic transmission patterns. Nevertheless, the core findings on plasmid-borne resistance and gene transfer efficiency are highly transferable to resistance modeling workflows and infection control research globally.

Protocol Parameters

• Broth microdilution for susceptibility testing: Follow CLSI or EUCAST guidelines; Ertapenem sodium salt is typically tested at serial two-fold dilutions, starting below 1 mg/L for Enterobacteriaceae.
• Plasmid conjugation assay: Use a donor:recipient ratio of 1:1; incubate overnight on non-selective media before plating on selective media with appropriate antibiotic concentrations to confirm gene transfer.
• PCR confirmation of CEGs: Design primers targeting bla_NDM-1, bla_IMP, and bla_KPC-2; validate with reference strains and include negative controls.
• Storage of Ertapenem sodium salt: Prepare stock solutions in water at ≥52 mg/mL, store at -20°C, and use within short-term experimental windows to ensure stability (product information).

Research Support Resources

For researchers modeling resistance in Gram-negative and Gram-positive bacteria or dissecting transmission dynamics, Ertapenem (sodium salt) (SKU C3451) from APExBIO offers a high-purity, water-soluble antibacterial agent suitable for susceptibility testing, gene transfer assays, and resistance mechanism studies. Its pharmacokinetic and solubility properties facilitate standardized experimental protocols. As always, this compound is intended strictly for research use and should not be applied to diagnostic or therapeutic contexts.